期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Multiple Sclerosis Journal According to the latest JCR data, this journal is indexed in the JCR. A previous title of this journal is MULT SCLER) LetPub Score 7.5
50 ratings
Rate
Reputation 8.7 Influence 6.2 Speed 9.6 | ||||||||||||||||||||
期刊簡稱 | MULT SCLER J | ||||||||||||||||||||
ISSN | 1352-4585 | ||||||||||||||||||||
E-ISSN | 1477-0970 | ||||||||||||||||||||
h-index | N.A. | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 10.40%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | https://uk.sagepub.com/en-gb/asi/multiple-sclerosis-journal/journal201820 | ||||||||||||||||||||
在線稿件提交 | https://uk.sagepub.com/en-gb/asi/multiple-sclerosis-journal/journal201820#submission-guidelines | ||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||
出版商 | SAGE Publications Ltd | ||||||||||||||||||||
主題領域 | CLINICAL NEUROLOGY | ||||||||||||||||||||
出版國/地區 | ENGLAND | ||||||||||||||||||||
發行頻率 | |||||||||||||||||||||
創刊年 | 0 | ||||||||||||||||||||
每年文章數 | 163每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 35.11% | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1352-4585%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: | ||||||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Multiple Sclerosis Journal] 的評論 | 撰寫評論 |
作者: Jeff Masefield 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-24 10:15:16 評論於 Review Speed: 3.0 | Submission Acceptance Rate: 50.0 Research Focus: Clinical Diagnosis and Treatment; Experience Sharing on NMOSD: MS and NMOSD are relatively good journals in this small specialized field. I submitted a review article, and the reviewers were very professional, providing many specific revision suggestions. I made 2 revisions. The review speed was also acceptable. Submit (12-jul-2023) Major revision (04-aug-2023) Re-submit (21-aug-2023) Minor revision (12-sep-2023) Re-submit (18-sep-2023) Accept (20-oct-2023(0) 讚! | Jeff Masefield |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 14:03:41 評論於 Select the issues to be discussed in depth; discuss the selected issues from multiple perspectives in a certain hierarchy, with reasoning based on facts, and the problems should be clearly and thoroughly explained(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 13:53:01 評論於 It is generally believed to be this way(0) 讚! | 维尔娜菲茨杰拉德 |
作者: Darlene Pepys 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 10:31:06 評論於 What does it mean to have a deep discussion / How can we deepen the discussion?(0) 讚! | Darlene Pepys |
作者: 魂魄彦露 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 12:25:32 評論於 Is it necessary to include an overview of the article in the first paragraph of a discussion?(0) 讚! | 魂魄彦露 |
作者: 珉林水芸 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-10-25 14:48:41 評論於 Direct rejection without clear reasons, suggest considering online platforms(0) 讚! | 珉林水芸 |
作者: sophia001 領域: 医学 審稿時間: 1.0 month(s) 結果: 拒稿 撰寫評論 |
2018-10-25 09:20:17 評論於 Directly rejected, the reason is unknown, it is recommended to switch to online(0) 讚! | sophia001 |
作者: lin 領域: 医药科学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2018-06-27 14:34:49 評論於 Very professional!I did not expect to increase points!(0) 讚! | lin |
作者: 灵松小姐姐 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-06-27 08:48:41 評論於 Very professional! Didn't expect to get a higher grade!(0) 讚! | 灵松小姐姐 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-16 11:32:11 評論於 Stuck in this bottleneck, it's not easy to make further progress, but with a score of over 4 points, it can be considered satisfactory(0) 讚! | 凌霄高洁 |
作者: 金顶蒙雨 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-09-02 12:06:55 評論於 Review speed: 6.0 | Submission hit rate: 25.0 Experience sharing: illogical, unclear expression, directly rejected(0) 讚! | 金顶蒙雨 |
作者: Anonymous 領域: 医药科学 審稿時間: 1.0 month(s) 結果: 拒稿 撰寫評論 |
2016-09-02 11:11:39 評論於 The logic is unknown, the expression is unclear, and the second is rejected.(0) 讚! | Anonymous |
作者: 宗室笑卉 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-04-05 15:43:55 評論於 Review Speed: 1.0 | Submission Acceptance Rate: 25.0 Experience Sharing: Submitted two case studies, both were rejected immediately, reason being insufficient depth in content(0) 讚! | 宗室笑卉 |
作者: Hayden Lewis 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-06-16 10:36:41 評論於 Review speed: 1.0 Experience sharing: Submitted a case study, rejected after 3 weeks, no review comments, citing too many submissions(0) 讚! | Hayden Lewis |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2014-03-10 14:45:56 評論於 The journal focuses on the aetiology and pathogenesis of demyelinating and inflammatory diseases of the central nervous system and on the application of such studies to scientifically based therapy. The following research areas are of particular interest to the journal: Clinical neurology Myelin chemistry Neuroimaging Pathobiology of the blood/brain barrier Glial pathobiology/myelin repair Pathology Epidemiology Therapeutics Genetics Immunology Virology Psychology Rehabilitation(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2013-05-04 11:17:25 評論於 A very professional magazine, the editors and reviewers are professionals engaged in multiple sclerosis research, which is relatively niche domestically. It is easier to publish if it is a long-term study in this field. It does not require too much innovation, but it demands a complete experimental design and rich data(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-06-29 15:57:13 評論於 Bullish, will it rise again next year?(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us